Variants in the LPS-receptor TLR4 and the LPS-binding receptor TREM2 are also associated with increased AD risk, further establishing the genetic connection between AD and endotoxin (Ghosh et al. 2020; Millischer et al. 2021). Here, TREM2 is linked to Alzheimer disease.